Eli Lilly and Company (LLY)
Create an Alert
52.35
-0.01 -0.02%
NYSE
Jun 18, 8:00PM
BATS Real time
Currency in USD
Eli Lilly and Company Return on Equity:
30.87% for March 31, 2013Eli Lilly and Company Historical Return on Equity Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 30.87% |
| Dec. 31, 2012 | 27.81% |
| Sept. 30, 2012 | 27.91% |
| June 30, 2012 | 27.97% |
| March 31, 2012 | 30.03% |
| Dec. 31, 2011 | 31.40% |
| Sept. 30, 2011 | 34.11% |
| June 30, 2011 | 37.22% |
| March 31, 2011 | 40.87% |
| Dec. 31, 2010 | 45.88% |
| Sept. 30, 2010 | 45.65% |
| June 30, 2010 | 45.74% |
| March 31, 2010 | 46.17% |
| Dec. 31, 2009 | 50.99% |
| Sept. 30, 2009 | -2.31% |
| June 30, 2009 | -15.76% |
| March 31, 2009 | -15.76% |
| Dec. 31, 2008 | -16.28% |
| Sept. 30, 2008 | 17.27% |
| June 30, 2008 | 28.11% |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Return on Equity (ROE)
Return on equity (ROE) measures the rate of return on the money invested by common stock owners and retained by the company thanks to previous profitable years. It demonstrates a company's ability to generate profits from shareholders' equity (also known as net assets or assets minus liabilities).
ROE shows how well a company uses investment funds to generate growth. Return on equity is useful for comparing the profitability of companies within a sector or industry.
Investors generally are interested in company's that have high, increasing returns on equity.
Learn More
LLY Return on Equity Benchmarks
| Companies | |
|---|---|
| Pfizer | 19.04% |
| GlaxoSmithKline | 60.64% |
| Abbott Laboratories | 20.85% |
LLY Return on Equity Rankings
| Overall |
97th percentile 477 of 16770 |
| Sector |
97th percentile 38 of 1408 in Healthcare |
| Industry |
94th percentile 8 of 135 in Drug Manufacturers - Major |
LLY Return on Equity Range, Past 5 Years
| Minimum | -16.28% | Dec 2008 |
| Maximum | 50.99% | Dec 2009 |
| Average | 25.89% |
